Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AtriCure, Inc. Director's Dealing 2012

Nov 5, 2012

31802_dirs_2012-11-05_b6f20390-ac95-4f79-acf0-3edcdac33c52.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: AtriCure, Inc. (ATRC)
CIK: 0001323885
Period of Report: 2012-11-01

Reporting Person: Wade M. Andrew (Vice President, Finance)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 5820 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Non-Qualified Stock Option (right to buy) $11.65 2017-12-05 Common Stock (2000) Direct
Non-Qualified Stock Option (right to buy) $1.50 2019-02-10 Common Stock (1000) Direct
Non-Qualified Stock Option (right to buy) $11.20 2021-02-09 Common Stock (1000) Direct
Non-Qualified Stock Option (right to buy) $6.27 2022-10-25 Common Stock (35000) Direct

Footnotes

F1: Includes 4,500 shares of unvested restricted stock awarded under the AtriCure, Inc. 2005 Equity Incentive Plan.

F2: The option vests and is exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and is exercisable in equal monthly installments on the same day of the month over the following three years.